Login / Signup
High cost oncology drugs without proof of added benefit are burdening health systems.
Francine Brinkhuis
Wim G Goettsch
Aukje K Mantel-Teeuwisse
Lourens T Bloem
Published in:
BMJ (Clinical research ed.) (2024)
Keyphrases
</>
palliative care